ArticleJournal of prevention (2022)2023
Human Papillomavirus Vaccination in Male University Students in Turkey: Coverage Rate, Barriers, and Associated Factors.
Article in Journal of prevention (2022), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
8 citing papers in PubMed, 1 synthesis or guideline pooled it, 11 citations in OpenAlex.
- Awareness and acceptance of human papillomavirus vaccine in the Middle East: A systematic review, meta-analysis, and meta-regression of 159 studies.Epidemiology and infection · 2024Pooled it
- HPV vaccination willingness and its determinants among male university students post-approval of male-specific HPV vaccines in China: a large-scale cross-sectional study.BMC public health · 2026Article
- Research Trends and Gaps in Human Papillomavirus Vaccination Intention in South Korea: A Scoping Review.Healthcare (Basel, Switzerland) · 2026Review
- Revisiting HPV vaccination post-COVID: geopolitical, sociocultural, and ethical disparities in global health.International journal for equity in health · 2025Review
- A Cross-Sectional Look at HPV Vaccine Acceptance and Associated Factors Among Male University Students in Lebanon.Advances in urology · 2025Article
- Males' Access to Human Papillomavirus Vaccination in Resource-Limited Settings.ImmunoTargets and therapy · 2024Article
- Review
- Knowledge and Attitude of Turkish Male Health Care Workers Regarding Human Papillomavirus and Vaccination.American journal of men's healthArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The human papillomavirus (HPV) vaccine is one of the most effective public health measures for preventing HPV-related cancers and other diseases. However, vaccination coverage is not at the desired level, especially among men. In this context, we aimed to determine HPV vaccination rates, barriers, and some related demographic and personal factors among male university students in Turkey. We shared an online questionnaire prepared by the authors in line with the relevant literature on social media platforms and included 1723 male university students in this cross-sectional study. Only 4.9% of the students stated that they were vaccinated against HPV, and the most important obstacle to vaccination was not knowing when to be vaccinated (49.5%). Additionally, marital status, sexual orientation, chronic diseases, family history of cervical cancer, and having heard of HPV were significant predictors of HPV vaccination.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.